ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Inc. (ALXO) is a healthcare company (biotechnology) based in the United States. The share price is $1.03, up 2.50% on the day, which values the company at $141.73M. Price as of 17 Nov 2026, 17:43 UTC, from Yahoo Finance.

Key facts

Share price
$1.03+2.50% today
Market value
$141.73M
200-week average
$4.4677% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

ALX Oncology Holdings Inc. in more detail

ALXO trades at -1.9× next year's expected earnings. It sits 77% below its 200-week average of $4.46.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold ALXO, including Peter Kolchinsky (0.2% of the portfolio).

Superinvestors holding ALXO

1 of the investors tracked here report a position in their latest 13F filing.

ALX Oncology Holdings Inc. (ALXO): questions and answers

What is ALX Oncology Holdings Inc.'s market cap?

ALX Oncology Holdings Inc. is valued at $141.73M at a share price of $1.03.

Is ALXO above its 200-week moving average?

No. ALXO is 77.0% below its 200-week average of $4.46. Long-term investors watch that line because strong companies rarely trade below it for long.

Does ALXO pay a dividend?

ALX Oncology Holdings Inc. does not currently pay a regular dividend.

Which famous investors own ALXO?

In their latest quarterly filings, Peter Kolchinsky (0.2% of the portfolio) hold ALXO. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “ALX Oncology Holdings Inc. (ALXO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ALXO

Underlying data: Yahoo Finance; company filings with the SEC.